KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Asset Utilization Ratio: 2011-2024

Historic Asset Utilization Ratio for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to 0.65.

  • Emergent BioSolutions' Asset Utilization Ratio fell 10.95% to 0.55 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.55, marking a year-over-year decrease of 10.95%. This contributed to the annual value of 0.65 for FY2024, which is 54.45% up from last year.
  • According to the latest figures from FY2024, Emergent BioSolutions' Asset Utilization Ratio is 0.65, which was up 54.45% from 0.42 recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Asset Utilization Ratio registered a high of 0.65 during FY2024, and its lowest value of 0.36 during FY2022.
  • In the last 3 years, Emergent BioSolutions' Asset Utilization Ratio had a median value of 0.42 in 2023 and averaged 0.48.
  • Per our database at Business Quant, Emergent BioSolutions' Asset Utilization Ratio slumped by 39.91% in 2022 and then soared by 54.45% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Asset Utilization Ratio (Yearly) stood at 0.61 in 2020, then climbed by 0.31% to 0.61 in 2021, then tumbled by 39.91% to 0.36 in 2022, then increased by 15.25% to 0.42 in 2023, then spiked by 54.45% to 0.65 in 2024.